Cynosure Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$819K Buy
7,844
+2,439
+45% +$255K 0.09% 113
2025
Q1
$630K Sell
5,405
-1,142
-17% -$133K 0.09% 134
2024
Q4
$554K Sell
6,547
-1,383
-17% -$117K 0.08% 131
2024
Q3
$713K Buy
+7,930
New +$713K 0.1% 123